Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

First macrolide LHRH antagonists patented by Abbott

Oct. 28, 1999

New distamycin derivatives developed at Pharmacia & Upjohn for cancer Rx

Oct. 28, 1999

Dramatic results described for STI-571 in CML patients

Oct. 27, 1999

Second-generation virus from Calydon begins clinical testing in prostate cancer

Oct. 27, 1999

Antisense oligonucleotides that modulate human HER-2 expression patented

Oct. 27, 1999

Polyamine derivatives designed at U. of Florida for reduced toxicity

Oct. 26, 1999

Novel oncological compounds acting as antagonists of protein-carbohydrate binding

Oct. 26, 1999

New antitumor diterpenes discovered in China

Oct. 26, 1999

U. of Minnesota designs anticancer, antiviral phosphoramidated nucleosides

Oct. 25, 1999

Cancer immunotherapy method available for licensing from NIH

Oct. 25, 1999

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...